CEO & Founder IamFluidics BV Enschede, Overijssel, Netherlands
Introduction: Injectable microparticles are widely used in long-acting drug delivery and regenerative aesthetic applications. However, conventional production methods often yield polydisperse, irregular, or non-degradable particles with poor injectability and associated safety concerns. These limitations can lead to nozzle clogging, tissue irritation, and uncontrolled foreign body responses. In this work, we demonstrate the potential of IN-AIR MICROFLUIDICS as a scalable approach to produce highly uniform, bioresorbable microparticles with controlled properties.
Learning Objectives:
Understand how IN-AIR MICROFLUIDICS enables controlled formation of injectable microparticles.
Obtain insight in how process conditions influence drug encapsulation and release behavior.
Evaluate strategies to scale microfluidic production from gram per day to kilogram per day throughput.